Compositions and methods for topical application and transdermal delivery of an oligopeptide

Details for Australian Patent Application No. 2006218455 (hide)

Owner Revance Therapeutics, Inc.

Inventors Dake, Michael D.; Waugh, Jacob M.

Agent Freehills

Pub. Number AU-A-2006218455

PCT Pub. Number WO2006/094193

Priority 60/658,741 03.03.05 US

Filing date 3 March 2006

Wipo publication date 8 September 2006

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094193 Priority application(s): WO2006/094193

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218460-Surfaces coated with target-induced fluorescent compounds for detection of target elements

2006218454-Humanized L243 antibodies